Related Experiment Video
Updated: May 30, 2026

The Tail Suspension Test
Published on: January 28, 2012
Utility of some genetic marker in predicting response to lithium
P R Geetha1, S M Channabasavanna
1Psychiatrist, Department of Psychiatry, NIMHANS, Bangalore.
Abstract:
One hundred manic patients who were treated with lithium were studied to find out the possibility of genetic variations in response to lithium. Along with pedigree study, test of colour blindness and ABO blood grouping were used as genetic markers. The study supports the transmission by autosomal dominance with incomplete penetrance. There is no difference between the responders and non-responders in the mode of transmission and in the family history of mental illness, ABO blood grouping.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics and Pharmacogenomics: Overview
